CGTX

COGNITION THERAPEUTICS INC

• NASDAQ·5d ago

  Cognition Therapeutics, Inc. Aligns with FDA on Pivotal Phase 3 Trial of Zervimesine in Dementia with Lewy Bodies

• NASDAQ·5d ago

  Cognition Aligns With FDA On Pivotal Phase 3 Study For Dementia With Lewy Bodies; Stock Up

• TipRanks·5d ago

  Cognition Therapeutics aligns with FDA on Phase 3 trial of zervimesine

• Benzinga·5d ago

  Cognition Therapeutics Aligns With FDA On Key Elements Of Phase 3 Study In Dementia With Lewy Bodies Including Patient Selection, Dose, Duration, And Endpoints

• TipRanks·10/14 15:35

  Cognition Therapeutics: Patent Extension and Pivotal CNS Catalysts Support Buy Rating with Unchanged $3 Price Target

• TipRanks·10/13 10:11

  Cognition Therapeutics issued patent covering novel crystalline form UPSTO

• TipRanks·10/13 10:11

  Cognition Therapeutics issued patent extending protection for zervimesine

• Benzinga·10/13 10:08

  Cognition Therapeutics Receives U.S. Patent Covering A Polymorph Version Of Its Lead Drug Candidate Zervimesine

• TipRanks·10/05 10:50

  Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT)

• NASDAQ·09/29 22:17

  Cognition Set For Type C FDA Meeting In Oct '26 On Planned Phase 3 For Dementia Drug Zervimesine

• TipRanks·09/29 11:36

  Cognition Therapeutics schedules Type C meeting with FDA for trial of CT1812

• Benzinga·09/29 11:32

  Cognition Therapeutics' Type C Meeting With FDA To Take Place Oct. 20 For Planned Trial Of Zervimesine

• Seeking Alpha·09/24 16:37

  Cullinan drops after delaying early-stage trial data for arthritis therapy

• TipRanks·09/21 17:56

  Cognition Therapeutics (CGTX) Receives a Buy from H.C. Wainwright

• TipRanks·08/13 10:30

  Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Talphera (TLPH) and Cognition Therapeutics (CGTX)